Literature DB >> 21599885

No evidence for association between SLC11A1 and visceral leishmaniasis in India.

Sanjana Mehrotra1, Joyce Oommen, Anshuman Mishra, Medhavi Sudharshan, Puja Tiwary, Sarra E Jamieson, Michaela Fakiola, Deepa Selvi Rani, Kumarasamy Thangaraj, Madhukar Rai, Shyam Sundar, Jenefer M Blackwell.   

Abstract

BACKGROUND: SLC11A1 has pleiotropic effects on macrophage function and remains a strong candidate for infectious disease susceptibility. 5' and/or 3' polymorphisms have been associated with tuberculosis, leprosy, and visceral leishmaniasis (VL). Most studies undertaken to date were under-powered, and none has been replicated within a population. Association with tuberculosis has replicated variably across populations. Here we investigate SLC11A1 and VL in India.
METHODS: Nine polymorphisms (rs34448891, rs7573065, rs2276631, rs3731865, rs17221959, rs2279015, rs17235409, rs17235416, rs17229009) that tag linkage disequilibrium blocks across SLC11A1 were genotyped in primary family-based (313 cases; 176 families) and replication (941 cases; 992 controls) samples. Family- and population-based analyses were performed to look for association between SLC11A1 variants and VL. Quantitative RT/PCR was used to compare SLC11A1 expression in mRNA from paired splenic aspirates taken before and after treatment from 24 VL patients carrying different genotypes at the functional promoter GTn polymorphism (rs34448891).
RESULTS: No associations were observed between VL and polymorphisms at SLC11A1 that were either robust to correction for multiple testing or replicated across primary and replication samples. No differences in expression of SLC11A1 were observed when comparing pre- and post-treatment samples, or between individuals carrying different genotypes at the GTn repeat.
CONCLUSIONS: This is the first well-powered study of SLC11A1 as a candidate for VL, which we conclude does not have a major role in regulating VL susceptibility in India.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21599885      PMCID: PMC3128845          DOI: 10.1186/1471-2350-12-71

Source DB:  PubMed          Journal:  BMC Med Genet        ISSN: 1471-2350            Impact factor:   2.103


  31 in total

1.  Implementing a unified approach to family-based tests of association.

Authors:  N M Laird; S Horvath; X Xu
Journal:  Genet Epidemiol       Date:  2000       Impact factor: 2.135

Review 2.  Diagnosis and treatment of Indian visceral leishmaniasis.

Authors:  Shyam Sundar; B Benjamin
Journal:  J Assoc Physicians India       Date:  2003-02

Review 3.  Genetics and visceral leishmaniasis in the Sudan: seeking a link.

Authors:  Jenefer M Blackwell; Hiba S Mohamed; Muntaser E Ibrahim
Journal:  Trends Parasitol       Date:  2004-06

4.  Resistance to treatment in Kala-azar: speciation of isolates from northeast India.

Authors:  S Sundar; K Pai; R Kumar; K Pathak-Tripathi; A A Gam; M Ray; R T Kenney
Journal:  Am J Trop Med Hyg       Date:  2001-09       Impact factor: 2.345

5.  Tumor necrosis factor (cachectin) in human visceral leishmaniasis.

Authors:  M Barral-Netto; R Badaró; A Barral; R P Almeida; S B Santos; F Badaró; D Pedral-Sampaio; E M Carvalho; E Falcoff; R Falcoff
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

6.  A prospective study of visceral leishmaniasis in an endemic area of Brazil.

Authors:  R Badaró; T C Jones; R Lorenço; B J Cerf; D Sampaio; E M Carvalho; H Rocha; R Teixeira; W D Johnson
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

7.  Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis.

Authors:  Agnes A Awomoyi; Arnaud Marchant; Joanna M M Howson; Keith P W J McAdam; Jenefer M Blackwell; Melanie J Newport
Journal:  J Infect Dis       Date:  2002-11-22       Impact factor: 5.226

8.  Expression of the SLC11A1 (NRAMP1) 5'-(GT)n repeat: opposite effect in the presence of -237C-->T.

Authors:  Monique G Zaahl; Kathryn J H Robson; Louise Warnich; Maritha J Kotze
Journal:  Blood Cells Mol Dis       Date:  2004 Jul-Aug       Impact factor: 3.039

Review 9.  Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Ity/Lsh/Bcg/Nramp1/Slc11a1 gene story.

Authors:  Jenefer M Blackwell; Susan Searle; Hiba Mohamed; Jacqueline K White
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

10.  SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan.

Authors:  Hiba Salah Mohamed; Muntaser Eltayeb Ibrahim; Elinor Nancy Miller; Jacqueline Katie White; Heather Jane Cordell; Joanna McCammond McGill Howson; Christopher Sean Peacock; Eltahir Awad Gasim Khalil; Ahmed Mohamed El Hassan; Jenefer Mary Blackwell
Journal:  Eur J Hum Genet       Date:  2004-01       Impact factor: 4.246

View more
  13 in total

Review 1.  Complex genetic origin of Indian populations and its implications.

Authors:  Rakesh Tamang; Lalji Singh; Kumarasamy Thangaraj
Journal:  J Biosci       Date:  2012-11       Impact factor: 1.826

2.  Genetic variants of SLC11A1 are associated with both autoimmune and infectious diseases: systematic review and meta-analysis.

Authors:  N S Archer; N T Nassif; B A O'Brien
Journal:  Genes Immun       Date:  2015-04-09       Impact factor: 2.676

3.  CD45RO+ T Cells and T Cell Activation in the Long-Lasting Immunity after Leishmania infantum Infection.

Authors:  João F Rodrigues-Neto; Gloria R Monteiro; Tatjana S L Keesen; Henio G Lacerda; Edgar M Carvalho; Selma M B Jeronimo
Journal:  Am J Trop Med Hyg       Date:  2017-12-21       Impact factor: 2.345

4.  Asymptomatic Leishmania infection: a new challenge for Leishmania control.

Authors:  Om Prakash Singh; Epco Hasker; David Sacks; Marleen Boelaert; Shyam Sundar
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

5.  Genetic and functional evaluation of the role of DLL1 in susceptibility to visceral leishmaniasis in India.

Authors:  Sanjana Mehrotra; Michaela Fakiola; Anshuman Mishra; Medhavi Sudarshan; Puja Tiwary; Deepa Selvi Rani; Kumarasamy Thangaraj; Madhukar Rai; Shyam Sundar; Jenefer M Blackwell
Journal:  Infect Genet Evol       Date:  2012-04-24       Impact factor: 3.342

6.  SLC11A1 (rs3731865) polymorphism and susceptibility to visceral leishmaniasis in HIV-coinfected patients from Northeastern Brazil.

Authors:  Walter Lins Barbosa Júnior; Alda Maria Justo; Ana Maria Aguiar Dos Santos; Rodrigo Feliciano do Carmo; Fábio Lopes de Melo; Luydson Richardson Silva Vasconcelos; Zulma Maria de Medeiros
Journal:  Parasitol Res       Date:  2020-01-06       Impact factor: 2.289

7.  Genetic and functional evaluation of the role of CXCR1 and CXCR2 in susceptibility to visceral leishmaniasis in north-east India.

Authors:  Sanjana Mehrotra; Michaela Fakiola; Joyce Oommen; Sarra E Jamieson; Anshuman Mishra; Medhavi Sudarshan; Puja Tiwary; Deepa Selvi Rani; Kumarasamy Thangaraj; Madhukar Rai; Shyam Sundar; Jenefer M Blackwell
Journal:  BMC Med Genet       Date:  2011-12-15       Impact factor: 2.103

Review 8.  Immune regulation during chronic visceral leishmaniasis.

Authors:  Rebecca J Faleiro; Rajiv Kumar; Louise M Hafner; Christian R Engwerda
Journal:  PLoS Negl Trop Dis       Date:  2014-07-10

9.  Immunobiology of visceral leishmaniasis.

Authors:  Rajiv Kumar; Susanne Nylén
Journal:  Front Immunol       Date:  2012-08-14       Impact factor: 7.561

10.  Lipoprotein lipase and PPAR alpha gene polymorphisms, increased very-low-density lipoprotein levels, and decreased high-density lipoprotein levels as risk markers for the development of visceral leishmaniasis by Leishmania infantum.

Authors:  Márcia Dias Teixeira Carvalho; Diego Peres Alonso; Célia Maria Vieira Vendrame; Dorcas Lamounier Costa; Carlos Henrique Nery Costa; Guilherme Loureiro Werneck; Paulo Eduardo Martins Ribolla; Hiro Goto
Journal:  Mediators Inflamm       Date:  2014-08-27       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.